3 Diabetes Biotechs That Could Surge 50% or More in 2018 Post author:Sam Post published:January 21, 2018 Post category:BioPharma Wall Street projects these three biotechs will grow the fastest over the next 12 months. Source: BioSpace You Might Also Like Europe's NeuroSearch Exploring Sale, Possible Liquidation of Company in the Next Few Months December 4, 2017 AI Firm Exscientia Grabs EUR250 Million Small Molecules Pact With Sanofi May 8, 2017 Bayer HealthCare Expansion Brings New Jobs to the Bay Area August 16, 2017
Europe's NeuroSearch Exploring Sale, Possible Liquidation of Company in the Next Few Months December 4, 2017
